Page 63 - B2B Connect

Bal Pharma appoints Akash Mathur as CEO

Mathur has vast pharma experience in the US & Canada including a start-up and advisory role to several small and medium companies followed by 10 years of working leading pharma companies

Claris Lifesciences receives US FDA approval for flumazenil injection

The approved product, which is primarily used to help reverse anaesthesia effect, is estimated to have market size of $ 4 million in the US

Claris Injectables receives five 483s from US FDA for plant in Ahmedabad

The company received 483s after US FDA's inspection, classified as prior approval inspection (PAI), which was conducted from August 16 to August 26, 2016

NPPA launches mobile App to provide real time drug prices

In the last two and a half years, National Pharmaceutical Pricing Authority (NPPA) has brought almost 900 formulations under the price control

PPP model can make India one of top 5 global pharma innovation hubs: Study

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research

Dutch firm AkzoNobel to set up powder coatings plant in Mumbai

The maker of Dulux paints will invest Euro 9 million (about Rs 67 crores) in the new plant, which will also make bonded metallic powders & localised products for markets such as pipe and re-bar co

Govt establishes Electropreneur Park to bolster electronics manufacturing

The park, set up at University of Delhi, will develop, promote, incubate, mentor, and create breakthrough innovations in the electronic systems design & manufacturing (ESDM) sector

Xpro suspends production at Faridabad unit

The plant produced coextruded plastic sheets and coextruded cast plastic films

Sadara Chemical operationalises mixed feed cracker

MFC, which can crack ethane (gas) as well as naphtha (liquid), will allow Sadara to produce a diversified range of plastics and chemical products

Carborundum Universal opens R&D centre in Tamil Nadu

The new R&D centre of CUMI, a part of the Murugappa Group, will focus on research in technical ceramics for industrial & advanced applications

Berry Plastics buys AEP Industries for $ 765 mn

With this, Berry Plastics adds highly complementary products and customers in North America

Government opens mega food park in Murshidabad

The mega food park to leverage an additional investment of about Rs 250 crore in food processing units in the park and generate a turnover of about Rs 500 crore annually

Bharat Electronics to invest Rs 300 cr in advanced night vision devices plant

The new facility, which will be built near Machilipatnam in Andhra Pradesh, will enable BEL to expand its electro-optics business

BEE introduces new star rating methodology for ACs

Standards for rating ACs have been continuously tightened over the years. The Star-5 in 2010 became Star-3 in 2015 and will become Star-1 in 2018 as per new ISEER methodology

Department of Pharma consults stakeholders on pricing mechanism for stents

The move aims to develop a science, safety and efficacy based price determination process for drug eluting stents, which have been recently included in NLEM (National List of Essential Medicine)

US FDA grants approval to Jubilant's hypertension drug felodipine

The approved product, felodipine extended-release tablet (2.5 mg, 5 mg, and 10 mg), is the generic version of Plendil tablets of AstraZeneca

CCEA gives nod to 9 railway projects worth Rs 24,375 cr

The approved railway lines are expected to help the upcoming industries in the region and additional transport capacity to meet their requirements

US patent office invalidates 2 patents of Teva's blockbuster drug Copaxone

The rule is in favour of Mylan, who has partnered with Natco Pharma in challenging the patent of the multiple sclerosis drug, Copaxone 40 mg injection, which has annual US sales of $3.3 bn

European drug regulator accepts Mylan & Biocon application for biosimilar trastuzumab

This is the second biosimilar developed by the two companies - who are collaborating for a broad portfolio of biosimilars and insulin analogs - that has been accepted for review in Europe

Material recycling leads $ 668 mn funding for circular economy technologies

Next-generation recycling is on the march as waste collection and sorting get a digital push from innovations in software, data analytics, and robotics, says Lux Research